Market Focus Target hospitals, clinics, physician offices, correctional facilities, workplaces, and occupational health clinics where rapid toxicology and point-of-care drug screens are in demand, leveraging Alere iCup and similar tests to expand penetration in the healthcare and enterprise screening segments.

Expansion Opportunities Leverage historical growth signals from acquired entities and product launches to pursue cross-sell of rapid diagnostics and point-of-care testing platforms to mid-size to large healthcare networks and workplace health programs in Europe and the Americas.

Product Pipeline Highlight the portfolio of rapid drug testing solutions, including point-of-care screens and malaria rapid tests, to address related infectious disease and substance abuse testing needs in hospitals, clinics, and community settings.

Technology Enablement Utilize digital marketing and analytics stack (Adobe Experience Manager, Act-On, Sizmek, Facebook Pixel) to run targeted campaigns for high-value buyer personas such as lab directors, occupational health leaders, and compliance officers, accelerating lead generation and nurture programs.

Financial Readiness With a revenue range of tens of millions and a leaner employee base, position offerings as cost-effective, high-margin testing solutions suitable for budget-conscious healthcare providers and enterprise customers seeking rapid ROI in drug testing and infectious disease screening.